{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,9]],"date-time":"2026-05-09T11:46:00Z","timestamp":1778327160877,"version":"3.51.4"},"reference-count":71,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2013,6,1]],"date-time":"2013-06-01T00:00:00Z","timestamp":1370044800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,6,1]],"date-time":"2013-06-01T00:00:00Z","timestamp":1370044800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jpagonline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pediatric and Adolescent Gynecology"],"published-print":{"date-parts":[[2013,6]]},"DOI":"10.1016\/j.jpag.2012.08.007","type":"journal-article","created":{"date-parts":[[2013,5,1]],"date-time":"2013-05-01T14:23:29Z","timestamp":1367418209000},"page":"132-137","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"title":["Menstrual Suppression in the Adolescent"],"prefix":"10.1016","volume":"26","author":[{"given":"Kelly L.","family":"Kantartzis","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gina S.","family":"Sucato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpag.2012.08.007_bib1","series-title":"Beyond Birth Control: The Overlooked Benefits of Oral Contraceptive Pills","author":"Jones","year":"2011"},{"key":"10.1016\/j.jpag.2012.08.007_bib2","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/S0029-7844(96)00488-7","article-title":"Extending the duration of active oral contraceptive pills to manage hormone withdrawal symptoms","volume":"89","author":"Sulak","year":"1997","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.jpag.2012.08.007_bib3","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/j.1526-4610.2007.00650.x","article-title":"Headaches and oral contraceptives: impact of eliminating the standard 7-day placebo interval","volume":"47","author":"Sulak","year":"2007","journal-title":"Headache"},{"key":"10.1016\/j.jpag.2012.08.007_bib4","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1093\/humrep\/deh869","article-title":"Randomized clinical trial of a levonorgestrel-releasing intrauterine system and a depot GnRH analogue for the treatment of chronic pelvic pain in women with endometriosis","volume":"20","author":"Petta","year":"2005","journal-title":"Hum Reprod"},{"key":"10.1016\/j.jpag.2012.08.007_bib5","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.jadohealth.2006.09.013","article-title":"Extended cycling of combined hormonal contraceptives in adolescents: physician views and prescribing practices","volume":"40","author":"Gerschultz","year":"2007","journal-title":"J Adolesc Health"},{"key":"10.1016\/j.jpag.2012.08.007_bib6","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/S0010-7824(99)00043-8","article-title":"Preferred frequency and characteristics of menstrual bleeding in relation to reproductive status, oral contraceptive use, and hormone replacement therapy use","volume":"59","author":"den Tonkelaar","year":"1999","journal-title":"Contraception"},{"key":"10.1016\/j.jpag.2012.08.007_bib7","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/0010-7824(96)00137-0","article-title":"Shorter pill-free interval in combined oral contraceptives decreases follicular development","volume":"54","author":"Spona","year":"1996","journal-title":"Contraception"},{"key":"10.1016\/j.jpag.2012.08.007_bib8","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.contraception.2003.09.004","article-title":"Attitude of German women and gynecologists towards long-cycle treatment with oral contraceptives","volume":"69","author":"Wiegratz","year":"2004","journal-title":"Contraception"},{"key":"10.1016\/j.jpag.2012.08.007_bib9","unstructured":"Association of Reproductive Health Professionals: Extended regimen oral\u00a0contraceptives. Harris Poll. June 14\u201317, 2002. [cited 2004 January 4, 2004]; Available from: http:\/\/www.arhp.org\/publications-and-resources\/studies-and-surveys\/2002-menstruation-survey. Accessed: 9\/16\/2012"},{"key":"10.1016\/j.jpag.2012.08.007_bib10","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.jadohealth.2011.01.015","article-title":"Autism spectrum disorders and menstruation","volume":"49","author":"Hamilton","year":"2011","journal-title":"J Adolesc Health"},{"key":"10.1016\/j.jpag.2012.08.007_bib11","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1097\/GCO.0b013e3283094b79","article-title":"Premenstrual syndrome and premenstrual dysphoric disorder in adolescents","volume":"20","author":"Rapkin","year":"2008","journal-title":"Curr Opin Obstet Gynecol"},{"key":"10.1016\/j.jpag.2012.08.007_bib12","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S1083-3188(00)00076-0","article-title":"Primary dysmenorrhea in adolescent girls and treatment with oral contraceptives","volume":"14","author":"Davis","year":"2001","journal-title":"J Pediatr Adolesc Gynecol"},{"key":"10.1016\/j.jpag.2012.08.007_bib13","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1080\/00016340500342912","article-title":"Bleeding disorders among young women: a population-based prevalence study","volume":"5","author":"Friberg","year":"2006","journal-title":"Acta Obstet Gynecol Scand"},{"key":"10.1016\/j.jpag.2012.08.007_bib14","first-page":"261","article-title":"Hormone withdrawal symptoms in oral contraceptive users","volume":"95","author":"Sulak","year":"2000","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.jpag.2012.08.007_bib15","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1016\/S0015-0282(03)00794-5","article-title":"Continuous use of an oral contraceptive for endometriosis-associated recurrent dysmenorrhea that does not respond to a cyclic pill regimen","volume":"80","author":"Vercellini","year":"2003","journal-title":"Fertil Steril"},{"key":"10.1016\/j.jpag.2012.08.007_bib16","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/j.contraception.2007.01.014","article-title":"Long-term assessment of symptomatology and satisfaction of an extended oral contraceptive regimen","volume":"75","author":"Coffee","year":"2007","journal-title":"Contraception"},{"key":"10.1016\/j.jpag.2012.08.007_bib17","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1016\/j.ajog.2006.05.012","article-title":"Oral contraceptives and premenstrual symptoms: comparison of a 21\/7 and extended regimen","volume":"195","author":"Coffee","year":"2006","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.jpag.2012.08.007_bib18","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1111\/j.1471-0528.2009.02372.x","article-title":"The levonorgestrel intrauterine system (Mirena) for the treatment of menstrual problems in adolescents with medical disorders, or physical or learning disabilities","volume":"117","author":"Pillai","year":"2010","journal-title":"BJOG"},{"key":"10.1016\/j.jpag.2012.08.007_bib19","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/S1474-4422(06)70376-3","article-title":"Tension-type headache in childhood and adolescence","volume":"5","author":"Anttila","year":"2006","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.jpag.2012.08.007_bib20","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1097\/01.mph.0000173175.95152.95","article-title":"Oral contraceptives and DDAVP nasal spray: patterns of use in managing vWD-associated menorrhagia: a single-institution study","volume":"27","author":"Amesse","year":"2005","journal-title":"J Pediatr Hematol Oncol"},{"key":"10.1016\/j.jpag.2012.08.007_bib21","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/S0010-7824(97)00156-X","article-title":"Effect of Depo-Provera or Microgynon on the painful crises of sickle cell anemia patients","volume":"56","author":"de Abood","year":"1997","journal-title":"Contraception"},{"issue":"2","key":"10.1016\/j.jpag.2012.08.007_bib22","first-page":"CD006261","article-title":"Steroid hormones for contraception in women with sickle cell disease","author":"Manchikanti","year":"2007","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jpag.2012.08.007_bib23","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1002\/cncr.22199","article-title":"Prevention of severe menorrhagia in oncology patients with treatment-induced thrombocytopenia by luteinizing hormone-releasing hormone agonist and depo-medroxyprogesterone acetate","volume":"107","author":"Meirow","year":"2006","journal-title":"Cancer"},{"key":"10.1016\/j.jpag.2012.08.007_bib24","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.ejogrb.2007.03.012","article-title":"Prevention and treatment of uterine bleeding in hematologic malignancy","volume":"134","author":"Quaas","year":"2007","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.jpag.2012.08.007_bib25","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1002\/pbc.23360","article-title":"The management of menstrual suppression and uterine bleeding: A survey of current practices in the pediatric blood and marrow transplant consortium","volume":"59","author":"Adegite","year":"2012","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.jpag.2012.08.007_bib26","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.jpag.2005.03.002","article-title":"Menstrual and contraceptive issues among young women with developmental delay: a retrospective review of cases at the Hospital for Sick Children, Toronto","volume":"18","author":"Dizon","year":"2005","journal-title":"J Pediatr Adolesc Gynecol"},{"key":"10.1016\/j.jpag.2012.08.007_bib27","first-page":"653","article-title":"Continuous combination oral contraceptive pills to eliminate withdrawal bleeding: a randomized trial","volume":"101","author":"Miller","year":"2003","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.jpag.2012.08.007_bib28","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.contraception.2006.07.005","article-title":"Evaluation of a continuous regimen of levonorgestrel\/ethinyl estradiol: phase 3 study results","volume":"74","author":"Archer","year":"2006","journal-title":"Contraception"},{"key":"10.1016\/j.jpag.2012.08.007_bib29","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1016\/j.contraception.2009.05.128","article-title":"Continuous, daily levonorgestrel\/ethinyl estradiol vs. 21-day, cyclic levonorgestrel\/ethinyl estradiol: efficacy, safety and bleeding in a randomized, open-label trial","volume":"80","author":"Teichmann","year":"2009","journal-title":"Contraception"},{"key":"10.1016\/j.jpag.2012.08.007_bib30","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1097\/01.AOG.0000175144.08035.74","article-title":"Extended regimens of the contraceptive vaginal ring: a randomized trial","volume":"106","author":"Miller","year":"2005","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.jpag.2012.08.007_bib31","doi-asserted-by":"crossref","first-page":"233","DOI":"10.2165\/00003088-200039030-00005","article-title":"Pharmacokinetics of etonogestrel and ethinylestradiol released from a combined contraceptive vaginal ring","volume":"39","author":"Timmer","year":"2000","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.jpag.2012.08.007_bib32","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.contraception.2005.03.005","article-title":"Comparison of ethinylestradiol pharmacokinetics in three hormonal contraceptive formulations: the vaginal ring, the transdermal patch and an oral contraceptive","volume":"72","author":"van den Heuvel","year":"2005","journal-title":"Contraception"},{"key":"10.1016\/j.jpag.2012.08.007_bib33","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1097\/01.AOG.0000160430.61799.f6","article-title":"Extended use of transdermal norelgestromin\/ethinyl estradiol: a randomized trial","volume":"105","author":"Stewart","year":"2005","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.jpag.2012.08.007_bib34","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.contraception.2006.01.001","article-title":"Risk of nonfatal venous thromboembolism in women using a contraceptive transdermal patch and oral contraceptives containing norgestimate and 35 microg of ethinyl estradiol","volume":"73","author":"Jick","year":"2006","journal-title":"Contraception"},{"key":"10.1016\/j.jpag.2012.08.007_bib35","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.contraception.2007.03.003","article-title":"Further results on the risk of nonfatal venous thromboembolism in users of the contraceptive transdermal patch compared to users of oral contraceptives containing norgestimate and 35 microg of ethinyl estradiol","volume":"76","author":"Jick","year":"2007","journal-title":"Contraception"},{"key":"10.1016\/j.jpag.2012.08.007_bib36","unstructured":"U.S. Food and Drug Administration: Ortho Evra Transdermal System Boxed Warning: Risk of Venous Thromboembolism. 2011 [11\/7\/2011]; Available: http:\/\/www.fda.gov\/Safety\/MedWatch\/SafetyInformation\/ucm211821.htm. Accessed: 2\/1\/12"},{"key":"10.1016\/j.jpag.2012.08.007_bib37","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.jadohealth.2011.01.008","article-title":"Transdermal contraception as a model for adolescent use of new methods","volume":"49","author":"Sucato","year":"2011","journal-title":"J Adolesc Health"},{"key":"10.1016\/j.jpag.2012.08.007_bib38","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.jadohealth.2009.02.007","article-title":"Attitudes toward the vaginal ring and transdermal patch among adolescents and young women","volume":"45","author":"Raine","year":"2009","journal-title":"J Adolesc Health"},{"key":"10.1016\/j.jpag.2012.08.007_bib39","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.contraception.2006.03.008","article-title":"Changes in bleeding patterns with depot medroxyprogesterone acetate subcutaneous injection 104 mg","volume":"74","author":"Arias","year":"2006","journal-title":"Contraception"},{"key":"10.1016\/j.jpag.2012.08.007_bib40","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.contraception.2009.02.008","article-title":"Menstrual pattern changes from levonorgestrel subdermal implants and DMPA: systematic review and evidence-based comparisons","volume":"80","author":"Hubacher","year":"2009","journal-title":"Contraception"},{"key":"10.1016\/j.jpag.2012.08.007_bib41","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/S0010-7824(01)00302-X","article-title":"Bleeding patterns and clinical performance of the levonorgestrel-releasing intrauterine system (Mirena) up to two years","volume":"65","author":"Hidalgo","year":"2002","journal-title":"Contraception"},{"key":"10.1016\/j.jpag.2012.08.007_bib42","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/S0010-7824(99)00104-3","article-title":"Factors affecting continuation rates of DMPA","volume":"60","author":"Hubacher","year":"1999","journal-title":"Contraception"},{"key":"10.1016\/j.jpag.2012.08.007_bib43","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/S0010-7824(01)00181-0","article-title":"Effect of counseling to improve compliance in Mexican women receiving depot-medroxyprogesterone acetate","volume":"63","author":"Canto De Cetina","year":"2001","journal-title":"Contraception"},{"key":"10.1016\/j.jpag.2012.08.007_bib44","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.contraception.2009.09.004","article-title":"Intrauterine contraception for adolescents aged 14-18 years: a multicenter randomized pilot study of levonorgestrel-releasing intrauterine system compared to the Copper T 380A","volume":"81","author":"Godfrey","year":"2010","journal-title":"Contraception"},{"key":"10.1016\/j.jpag.2012.08.007_bib45","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.contraception.2008.12.001","article-title":"A nationwide cohort study of the use of the levonorgestrel intrauterine device in New Zealand adolescents","volume":"79","author":"Paterson","year":"2009","journal-title":"Contraception"},{"key":"10.1016\/j.jpag.2012.08.007_bib46","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1097\/01.AOG.0000291575.93944.1a","article-title":"ACOG Committee Opinion No. 392, December 2007. Intrauterine device and adolescents","volume":"110","author":"American College of Obstetricians and Gynecologists","year":"2007","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.jpag.2012.08.007_bib47","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.contraception.2004.11.007","article-title":"Safety and efficacy of Implanon, a single-rod implantable contraceptive containing etonogestrel","volume":"71","author":"Funk","year":"2005","journal-title":"Contraception"},{"key":"10.1016\/j.jpag.2012.08.007_bib48","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1515\/ijamh.2011.013","article-title":"Menstrual bleeding patterns in adolescents using etonogestrel (ENG) implant","volume":"23","author":"Deokar","year":"2011","journal-title":"Int J Adolesc Med Health"},{"key":"10.1016\/j.jpag.2012.08.007_bib49","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1038\/sj.bmt.1701187","article-title":"Luteinizing hormone-releasing hormone analogue: leuprorelin acetate for the prevention of menstrual bleeding in premenopausal women undergoing stem cell transplantation","volume":"21","author":"Chiusolo","year":"1998","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jpag.2012.08.007_bib50","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1093\/humrep\/dei377","article-title":"Continuous versus cyclic use of combined oral contraceptives for contraception: systematic Cochrane review of randomized controlled trials","volume":"21","author":"Edelman","year":"2006","journal-title":"Hum Reprod"},{"key":"10.1016\/j.jpag.2012.08.007_bib51","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.contraception.2005.07.001","article-title":"Attitudes and prescribing preferences of health care professionals in the United States regarding use of extended-cycle oral contraceptives","volume":"73","author":"Sulak","year":"2006","journal-title":"Contraception"},{"key":"10.1016\/j.jpag.2012.08.007_bib52","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1097\/AOG.0b013e3181842071","article-title":"Frequency and management of breakthrough bleeding with continuous use of the transvaginal contraceptive ring: a randomized controlled trial","volume":"112","author":"Sulak","year":"2008","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.jpag.2012.08.007_bib53","unstructured":"Gallup Survey Reveals Women Ob-Gyns Benefit from \u201cInsider Knowledge\u201d. 2003 [August 6, 2011]; Available from: http:\/\/www.acog.org\/About_ACOG\/News_Room\/News_Releases\/2003\/Gallup_Survey_Reveals_Women_Ob-Gyns_Benefit_from_Insider_Knowledge. Accessed: 9\/16\/2012"},{"issue":"RR-4","key":"10.1016\/j.jpag.2012.08.007_bib54","first-page":"1","article-title":"U S. Medical Eligibility Criteria for Contraceptive Use, 2010","volume":"59","author":"Centers for Disease Control and Prevention","year":"2010","journal-title":"MMWR Recomm Rep"},{"key":"10.1016\/j.jpag.2012.08.007_bib55","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.1016\/j.fertnstert.2008.02.122","article-title":"Return to fertility after cessation of a continuous oral contraceptive","volume":"91","author":"Barnhart","year":"2009","journal-title":"Fertil Steril"},{"key":"10.1016\/j.jpag.2012.08.007_bib56","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.contraception.2006.07.009","article-title":"Endometrial histology following 1 year of a continuous daily regimen of levonorgestrel 90 micro g\/ethinyl estradiol 20 micro g","volume":"75","author":"Johnson","year":"2007","journal-title":"Contraception"},{"key":"10.1016\/j.jpag.2012.08.007_bib57","doi-asserted-by":"crossref","first-page":"2028","DOI":"10.1158\/0008-5472.CAN-11-4064","article-title":"Effect of depo-medroxyprogesterone acetate on breast cancer risk among women 20 to 44 years of age","volume":"72","author":"Li","year":"2012","journal-title":"Cancer Res"},{"key":"10.1016\/j.jpag.2012.08.007_bib58","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.1359\/jbmr.1999.14.10.1672","article-title":"A six-year longitudinal study of the relationship of physical activity to bone mineral accrual in growing children: the University of Saskatchewan bone mineral accrual study","volume":"14","author":"Bailey","year":"1999","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.jpag.2012.08.007_bib59","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.contraception.2006.01.003","article-title":"Combined hormonal contraception and bone health: a systematic review","volume":"73","author":"Martins","year":"2006","journal-title":"Contraception"},{"key":"10.1016\/j.jpag.2012.08.007_bib60","doi-asserted-by":"crossref","first-page":"2764","DOI":"10.1093\/humrep\/dei117","article-title":"The combined contraceptive vaginal ring and bone mineral density in healthy pre-menopausal women","volume":"20","author":"Massai","year":"2005","journal-title":"Hum Reprod"},{"key":"10.1016\/j.jpag.2012.08.007_bib61","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.contraception.2009.09.011","article-title":"Effects of the contraceptive patch and the vaginal ring on bone metabolism and bone mineral density: a prospective, controlled, randomized study","volume":"81","author":"Massaro","year":"2010","journal-title":"Contraception"},{"key":"10.1016\/j.jpag.2012.08.007_bib62","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.jpag.2009.04.008","article-title":"Bone accretion in adolescents using the combined estrogen and progestin transdermal contraceptive method Ortho Evra: a pilot study","volume":"23","author":"Harel","year":"2010","journal-title":"J Pediatr Adolesc Gynecol"},{"key":"10.1016\/j.jpag.2012.08.007_bib63","doi-asserted-by":"crossref","first-page":"2060","DOI":"10.1016\/j.fertnstert.2007.10.070","article-title":"Bone mineral density in adolescent females using injectable or oral contraceptives: a 24-month prospective study","volume":"90","author":"Cromer","year":"2008","journal-title":"Fertil Steril"},{"key":"10.1016\/j.jpag.2012.08.007_bib64","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1001\/archpedi.159.2.139","article-title":"Change in bone mineral density among adolescent women using and discontinuing depot medroxyprogesterone acetate contraception","volume":"159","author":"Scholes","year":"2005","journal-title":"Arch Pediatr Adolesc Med"},{"key":"10.1016\/j.jpag.2012.08.007_bib65","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.contraception.2009.11.003","article-title":"Recovery of bone mineral density in adolescents following the use of depot medroxyprogesterone acetate contraceptive injections","volume":"81","author":"Harel","year":"2010","journal-title":"Contraception"},{"key":"10.1016\/j.jpag.2012.08.007_bib66","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1097\/AOG.0b013e3181875b78","article-title":"Effects of depot medroxyprogesterone acetate and 20-microgram oral contraceptives on bone mineral density","volume":"112","author":"Berenson","year":"2008","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.jpag.2012.08.007_bib67","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1097\/AOG.0b013e318188d1ec","article-title":"ACOG Committee Opinion No. 415: Depot medroxyprogesterone acetate and bone effects","volume":"112","author":"American College of Obstetricians and Gynecologists Committee on Gynecologic Practice","year":"2008","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.jpag.2012.08.007_bib68","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1093\/humrep\/15.1.118","article-title":"Bone mineral density during long-term use of the progestagen contraceptive implant Implanon compared to a non-hormonal method of contraception","volume":"15","author":"Beerthuizen","year":"2000","journal-title":"Hum Reprod"},{"key":"10.1016\/j.jpag.2012.08.007_bib69","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1093\/humrep\/dei358","article-title":"A prospective study of the forearm bone density of users of etonorgestrel- and levonorgestrel-releasing contraceptive implants","volume":"21","author":"Bahamondes","year":"2006","journal-title":"Hum Reprod"},{"key":"10.1016\/j.jpag.2012.08.007_bib70","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.ijgo.2010.01.018","article-title":"Bone mineral density in women using the subdermal contraceptive implant Implanon for at least 2 years","volume":"109","author":"Pongsatha","year":"2010","journal-title":"Int J Gynaecol Obstet"},{"key":"10.1016\/j.jpag.2012.08.007_bib71","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.contraception.2010.08.001","article-title":"The management of unacceptable bleeding patterns in etonogestrel-releasing contraceptive implant users","volume":"83","author":"Mansour","year":"2011","journal-title":"Contraception"}],"container-title":["Journal of Pediatric and Adolescent Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1083318812001519?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1083318812001519?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T13:40:10Z","timestamp":1761054010000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1083318812001519"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,6]]},"references-count":71,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2013,6]]}},"alternative-id":["S1083318812001519"],"URL":"https:\/\/doi.org\/10.1016\/j.jpag.2012.08.007","relation":{},"ISSN":["1083-3188"],"issn-type":[{"value":"1083-3188","type":"print"}],"subject":[],"published":{"date-parts":[[2013,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Menstrual Suppression in the Adolescent","name":"articletitle","label":"Article Title"},{"value":"Journal of Pediatric and Adolescent Gynecology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpag.2012.08.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 North American Society for Pediatric and Adolescent Gynecology. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}